Seiji Wakao
Stock Analyst at J.P. Morgan
(0.41)
# 4,019
Out of 4,339 analysts
77
Total ratings
35%
Success rate
-9%
Average return
Main Sectors:
Stocks Rated by Seiji Wakao
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYO: 4568 Daiichi Sankyo Company, Limited | Maintained: Buy | ¥4,500 → ¥3,700 | $2,691.50 | +37.47% | 9 | Mar 26, 2026 | |
| TYO: 4151 Kyowa Kirin Co., Ltd. | Downgraded: Sell | ¥2,200 → ¥1,800 | $2,419.50 | -25.60% | 7 | Mar 3, 2026 | |
| TYO: 4519 Chugai Pharmaceutical Co., Ltd. | Maintained: Buy | ¥9,500 → ¥10,700 | $7,774.00 | +37.64% | 6 | Feb 6, 2026 | |
| TYO: 4506 Sumitomo Pharma Co., Ltd. | Maintained: Buy | ¥1,600 → ¥1,880 | $1,523.00 | +23.44% | 5 | Sep 5, 2025 | |
| TYO: 4503 Astellas Pharma Inc. | Maintained: Hold | ¥1,700 → ¥1,900 | $2,121.00 | -10.42% | 5 | Sep 4, 2025 | |
| TYO: 4523 Eisai Co., Ltd. | Maintained: Hold | ¥4,000 → ¥4,900 | $4,050.00 | +20.99% | 11 | Sep 4, 2025 | |
| TYO: 4516 Nippon Shinyaku Co., Ltd. | Maintained: Hold | ¥3,200 | $4,141.00 | -22.72% | 5 | Jul 22, 2025 | |
| TYO: 4528 Ono Pharmaceutical Co., Ltd. | Maintained: Sell | ¥1,400 → ¥1,300 | $2,365.00 | -45.03% | 4 | Jul 15, 2025 | |
| TYO: 4578 Otsuka Holdings Co., Ltd. | Maintained: Buy | ¥10,700 → ¥11,000 | $11,440.00 | -3.85% | 7 | Jul 15, 2025 | |
| TYO: 4536 Santen Pharmaceutical Co., Ltd. | Maintained: Buy | ¥2,200 → ¥2,600 | $1,901.50 | +36.73% | 3 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥1,050 → ¥1,000 | $1,068.00 | n/a | 2 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥2,100 → ¥2,200 | $3,028.00 | n/a | 5 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥4,500 | $5,118.00 | n/a | 3 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥1,800 | $1,061.00 | n/a | 1 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥4,700 → ¥5,000 | $3,258.00 | n/a | 2 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 | $15.87 | n/a | 2 | Sep 13, 2021 |
Daiichi Sankyo Company, Limited
Mar 26, 2026
Maintained: Buy
Price Target: ¥4,500 → ¥3,700
Current: $2,691.50
Upside: +37.47%
Kyowa Kirin Co., Ltd.
Mar 3, 2026
Downgraded: Sell
Price Target: ¥2,200 → ¥1,800
Current: $2,419.50
Upside: -25.60%
Chugai Pharmaceutical Co., Ltd.
Feb 6, 2026
Maintained: Buy
Price Target: ¥9,500 → ¥10,700
Current: $7,774.00
Upside: +37.64%
Sumitomo Pharma Co., Ltd.
Sep 5, 2025
Maintained: Buy
Price Target: ¥1,600 → ¥1,880
Current: $1,523.00
Upside: +23.44%
Astellas Pharma Inc.
Sep 4, 2025
Maintained: Hold
Price Target: ¥1,700 → ¥1,900
Current: $2,121.00
Upside: -10.42%
Eisai Co., Ltd.
Sep 4, 2025
Maintained: Hold
Price Target: ¥4,000 → ¥4,900
Current: $4,050.00
Upside: +20.99%
Nippon Shinyaku Co., Ltd.
Jul 22, 2025
Maintained: Hold
Price Target: ¥3,200
Current: $4,141.00
Upside: -22.72%
Ono Pharmaceutical Co., Ltd.
Jul 15, 2025
Maintained: Sell
Price Target: ¥1,400 → ¥1,300
Current: $2,365.00
Upside: -45.03%
Otsuka Holdings Co., Ltd.
Jul 15, 2025
Maintained: Buy
Price Target: ¥10,700 → ¥11,000
Current: $11,440.00
Upside: -3.85%
Santen Pharmaceutical Co., Ltd.
Jun 12, 2025
Maintained: Buy
Price Target: ¥2,200 → ¥2,600
Current: $1,901.50
Upside: +36.73%
Apr 8, 2025
Maintained: Hold
Price Target: ¥1,050 → ¥1,000
Current: $1,068.00
Upside: n/a
Mar 27, 2025
Maintained: Hold
Price Target: ¥2,100 → ¥2,200
Current: $3,028.00
Upside: n/a
Mar 27, 2025
Maintained: Hold
Price Target: ¥4,500
Current: $5,118.00
Upside: n/a
Oct 24, 2024
Maintained: Buy
Price Target: ¥1,800
Current: $1,061.00
Upside: n/a
Aug 26, 2024
Maintained: Buy
Price Target: ¥4,700 → ¥5,000
Current: $3,258.00
Upside: n/a
Sep 13, 2021
Maintained: Hold
Price Target: $18
Current: $15.87
Upside: n/a